Ascentage Pharma announced that its management team will participate in four upcoming investor conferences in New York this September.
Public source
Publisher name
Public post
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) is pleased to announce that our management team will participate in four upcoming investor conferences in New York this Septe…
Company
Ascentage Pharma
A Leader in the Discovery and Development of First and Best-in-class Small Molecule Cancer Therapies.
- Industry
- Biotechnology Research
- Location
- Suzhou, China, and Rockville, Maryland, United States, CN
- Company size
- 51–200 employees
About Ascentage Pharma
Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
ALX Oncology
ALX Oncology leadership will participate in three upcoming investor conferences this September, including Wells Fargo 21st Annual Healthcare Conference in Boston on September 9, Cantor Global Healthcare Conference in New York on September 10, and H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14.
Presence & Recognition
Verastem Oncology
Verastem Oncology management team is looking forward to participating in the upcoming Wells Fargo Healthcare Conference, the Cantor Global Healthcare Conference, and the H.C. Wainwright Annual Global Investment Conference to discuss progress across Verastem's commercial product and pipeline programs.
Presence & Recognition
Fore Biotherapeutics
Fore Biotherapeutics is participating in two upcoming investor conferences in September, Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, and Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15.
Presence & Recognition
Pyxis Oncology
Pyxis Oncology will participate in three upcoming investor conferences this September, including Wells Fargo 21st Annual Healthcare Conference, the 2026 Cantor Global Healthcare Conference, and the H.C. Wainwright 28th Annual Global Investment Conference.
Presence & Recognition
IDEAYA Biosciences